✓ Medically reviewed by Dr. Anjmun Sharma, MD · Updated 2026-06-024 min read

"Ozempic Face": What It Is and How to Minimize It

It is facial volume loss from losing weight quickly, not a special drug effect. Here is the honest explanation and what helps.

An elegant portrait in soft, natural lighting

What it actually is

"Ozempic face" is a nickname for the gaunt, hollow look that can come with fast weight loss. It is not caused by the medication itself; it is what happens to anyone's face when fat is lost quickly from the cheeks and temples. The same look can follow rapid weight loss from any method.

Why it happens

The face has fat pads that give it a youthful fullness. When you lose weight fast, those pads shrink along with the rest of your body fat, and skin that lost elasticity over time may not snap back, which reads as a more aged or hollow appearance.

Ready to start?

$199 Skeptics’ Trial, see if it works for you

One month of medical-grade compounded semaglutide, the $119 doctor review, and a free B-12/lipotropic injection. No long-term commitment.

Start the 30-day trial

How to minimize it (honest, practical)

The honest bottom line

Facial volume loss is a cosmetic trade-off of fast weight loss, not a reason to avoid treatment, and it is partly manageable with pace, protein, and care. This is general education, not medical or dermatologic advice.

What you can start today at New Hope Weight Loss

After a one-time $119 medical review with Dr. Sharma, eligible patients begin a physician-supervised program with compounded semaglutide from $166 a month or compounded tirzepatide from $233 a month, with a $199 one-month Skeptics' Trial. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality. Care is in person in Orange County and by telehealth across California and additional states.

Want a steady, supervised plan?

A $119 review with Dr. Sharma sets a sensible pace and protects muscle as you lose. Take the 2-minute quiz or call us.

Call (657) 837-3342

Frequently asked questions

Is "Ozempic face" caused by the drug?

No. It is facial volume loss from losing weight quickly, which can happen with any rapid weight loss, not a specific effect of semaglutide. The face loses fat along with the rest of the body.

Can I prevent it?

You can reduce it by losing at a steady, supervised pace, prioritizing protein and strength training to protect muscle, staying hydrated, and caring for your skin. Talk to your physician about pace and dose.

Does losing weight slower help?

A more gradual pace gives skin and facial fat more time to adjust, which many people find softens the effect. A supervised plan can adjust your pace.

Is it permanent?

It varies by person, skin elasticity, and age. Some fullness can return with maintenance and muscle work; cosmetic options exist but are outside our scope. This is general education, not advice.

How does New Hope Weight Loss approach this?

With a physician-supervised, steady plan and protein/strength guidance to support healthy composition. Compounded medications are not FDA-approved, and Dr. Sharma reviews what is appropriate for you.

This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.

Not ready to start? Get the details by email.

Pricing, how it works, and what to expect, sent to your inbox. No pressure, unsubscribe anytime.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.